🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is designed to characterize the absorption, metabolism, and excre...
Status
Completed
Location
Research Site
Start Date
2015-06
Trial ID
NCT02489513
Treatments Being Tested
The standard treatment for patients with acute myeloid leukemia (AML) with ...
Status
Recruiting
Location
AT-Feldkirch-IKHF
Start Date
2025-08-05
Trial ID
NCT07075016
Treatments Being Tested
The researchers are doing this study to find out whether a 3-drug combinati...
Status
Recruiting
Location
Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Start Date
2026-01-27
Trial ID
NCT07392242
Treatments Being Tested
This is a prospective, single-arm, single-center Phase II clinical study. I...
Status
Not Yet Recruiting
Location
Xinxiang Li
Start Date
2024-11-01
Trial ID
NCT06593548
Treatments Being Tested
In this study, response to treatment and (progression free and overall) sur...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2021-09-20
Trial ID
NCT04056910
Treatments Being Tested
This research study is studying a drug as a possible treatment for IDH1-mut...
Status
Completed
Location
Johns Hopkins Cancer Center
Start Date
2019-01-16
Trial ID
NCT03564821
Treatments Being Tested
In this trial the investigators aim to evaluate safety and efficacy of comb...
Status
Withdrawn
Location
Yale Cancer Center
Start Date
2020-02-12
Trial ID
NCT04044209
This study is being done to see whether AG-120 is an effective and safe tre...
Status
Active Not Recruiting
Location
Johns Hopkins Hospital (Data Collection Only)
Start Date
2020-03-04
Trial ID
NCT04278781
Treatments Being Tested
This phase II study compares the order of treatment with ivosidenib or enas...
Status
Recruiting
Location
University of Colorado
Start Date
2022-09-13
Trial ID
NCT05401097
Treatments Being Tested
maintenance of AML or MDS patients with known IDH1 mutation after allogenei...
Status
Recruiting
Location
Universitätsklinikum Aachen
Start Date
2025-06-17
Trial ID
NCT06717958
Treatments Being Tested